Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia
FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia
FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia
Submitted by
admin
on July 13, 2015 - 9:51am
Source:
BioPharma Dive
News Tags:
FDA
Otsuka
Lundbeck
schizophrenia
Rexulta
Headline:
FDA approves Otsuka/Lundbeck drug for both depression and schizophrenia
Do Not Allow Advertisers to Use My Personal information
